EpicGenetics Announces Research Activity with Mayo Clinic to Advance Fibromyalgia Diagnostics

LOS ANGELES–(BUSINESS WIRE)–EpicGenetics announced a contract with the Mayo Clinic Fibromyalgia and Chronic Fatigue Clinic to perform research to investigate the use of the EpicGenetics FM/a® Test to determine the test’s use and applicability to objectively diagnose fibromyalgia. “This collaboration is of tremendous importance to the estimated 20+ million patients in the United States who suffer from fibromyalgia,” said EpicGenetics CEO Dr. Bruce Gillis. “To have the Mayo Clinic investigate a